
    
      The supplement is composed by of a combination of glycirrhizic acid, Cinnamomun Zeylanicum
      and corosolic acid. They act in different way reducing insulin resistance, which is the main
      cause of metabolic syndrome. It was a randomized, controlled study involving 60 women with
      the metabolic syndrome following the criteria proposed by ATP III in 2015. Main outcomes were
      the improvement of the parameters that characterizes the metabolic syndrome, such as glucose
      and insulin levels, triglycerides, HDL-cholesterol and blood pressure.
    
  